Heartbeam Assets per Share

What does Heartbeam do? HeartBeam, Inc. generates revenue through its proprietary VECG technology platform, which includes two patented products: HeartBeam AIMI and HeartBeam AIMIGo. HeartBeam AIMI is software designed for acute care settings, offering 3D comparison of baseline and symptomatic 12-lead ECG to detect heart attacks. HeartBeam AIMIGo is a credit card-sized 12-lead ECG device paired with a smartphone app and cloud-based diagnostic software for remote heart attack detection. The company targets healthcare facilities and remote monitoring segments, focusing on cardiovascular diagnostic solutions for both in-hospital and out-of-hospital settings. HeartBeam AIMI is sold to acute care providers such as hospitals and emergency departments, while HeartBeam AIMIGo serves patients and remote healthcare services seeking continuous cardiac monitoring. The firm's revenue streams derive from the commercialization of these two products, leveraging its patented VECG technology to provide higher resolution ambulatory ECG solutions. The company's focus on detecting and monitoring cardiac disease outside traditional healthcare facilities drives its product development and sales strategy. HeartBeam Inc. operates in the cardiovascular diagnostic technology sector, with its products designed to enable cardiac disease detection both inside and outside healthcare facilities. The firm's VECG platform allows for 3D vector imaging of cardiac electrical activity, enhancing diagnostic capabilities beyond standard ECG methods. Revenue is generated through the sale of software, devices, and cloud-based diagnostic systems tailored to specific healthcare environments and remote monitoring needs. Heartbeam is one of the most popular companies on Eulerpool.